Form 4: 2seventy bio CEO William Baird III Receives Stock Awards

2seventy bio's CEO, William Baird III, was granted 264,000 shares of restricted stock and options to purchase 176,000 shares on January 6, 2025.

Summary

• William Baird III, the President and CEO of 2seventy bio, Inc., received a grant of 264,000 shares of common stock on January 6, 2025.
• These shares are restricted and will vest over a four-year period, with the first installment vesting on January 2, 2026.
• Mr. Baird also received stock options for 176,000 shares of common stock, exercisable at $2.64 per share.
• These options vest over a four-year period, with 25% vesting on January 2, 2026, and the remainder vesting in 36 equal monthly installments thereafter.
• Both the stock and options are subject to Mr. Baird's continued service with the company.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The stock and option grants align the CEO's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the CEO.

Risks

• The value of the stock and options is dependent on the future performance of 2seventy bio.
• The CEO must remain employed by the company to fully realize the value of the grants.

Industry Context

This type of stock and option grant is a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option and restricted stock grants are standard practice for executive compensation in the biotech industry.
• Vesting schedules over four years are typical to ensure long-term commitment from executives.
• The specific amounts and terms of the grants would need to be compared to similar companies to assess if they are in line with industry norms.

Stakeholder Impact

• Shareholders may view the grants positively as they incentivize the CEO to increase the company's value.
• Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock, executive compensation, insider trading, 2seventy bio, TSVT, William Baird III